Skip to content

The effects of Mindfulness-Based Stress Reduction program on stress, subjective anxiety, self-compassion, and prenatal attachment in pregnant women with perinatal loss: A randomized controlled trial.

Hatice Gül Öztaş, Esra Sabancı Baransel, Zeynep Aktaş

Death Studies January 18, 2026 DOI: 10.1080/07481187.2026.2613244 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Randomized controlled trial Peer reviewed
Sample size 112
Population Pregnant women with perinatal loss
Intervention Mindfulness-Based Stress Reduction (MBSR)
Duration 4-week intervention
Topics Anxiety Meditation
Key findings MBSR significantly reduced stress and anxiety and improved self-compassion and prenatal attachment in pregnant women with perinatal loss.

Abstract

This randomized controlled trial investigated the effects of the Mindfulness-Based Stress Reduction (MBSR) program on stress, subjective anxiety, self-compassion, and prenatal attachment in pregnant women with perinatal loss. A total of 112 women were randomly assigned to MBSR (n = 56) or control (n = 56) groups. The MBSR program was delivered face-to-face in eight sessions over 4 weeks. Pretest comparisons showed no significant differences between groups (p >.05). Posttest results indicated that the MBSR group had significantly lower Tilburg Pregnancy Distress Scale (partner involvement and negative affect) and Subjective Units of Disturbance Scale scores, with large effect sizes (η2 = .677, .679, .143, .621). The MBSR group also showed significantly higher Self-Compassion Scale-Short Form scores (η2 = .542) and higher Maternal Antenatal Attachment Scale scores, including both time spent on attachment and attachment quality (η2 = .620, .760, .557). Findings suggest MBSR effectively reduces stress and anxiety while enhancing self-compassion and prenatal attachment in women with perinatal loss.

Comparable studies

Other randomized controlled trials on anxiety, most cited first.

Study Year Design Participants
Prevention of relapse/recurrence in major depression by mindfulness-based cognitive therapy. Recovered recurrently depressed patients 2000 Randomized controlled trial n = 145
Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial Cancer patients with life-threatening diagnoses and symptoms of depression and/or anxiety 2016 Randomized controlled trial n = 51
Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial Patients with cancer-related anxiety and depression 2016 Double-blind, placebo-controlled, crossover trial n = 29
Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance Hallucinogen-naïve adults reporting regular participation in religious or spiritual... 2006 Double-blind study n = 36
Pilot Study of Psilocybin Treatment for Anxiety in Patients With Advanced-Stage Cancer Adults with advanced-stage cancer and anxiety 2010 Double-blind, placebo-controlled study n = 12

Citations in the library

Explore topics